Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
Axithra has raised $10.7M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Axithra's investors include imec.xpand, Kurma Partners, White Fund, Werfen, Hamamatsu Photonics.
Axithra is headquartered in Genk, Belgium.
Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
Axithra is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Axithra — Funding & Investors." VCBacked, September 5, 2023, https://www.vcbacked.co/company/axithra. Accessed August 13, 2026.
VCBacked. (2023). Axithra — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/axithra
{{cite web |title=Axithra — Funding & Investors |url=https://www.vcbacked.co/company/axithra |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated